← Leaderboards
Benjamin Lebwohl
Columbia University Health Sciences
$2,482,568
Attributed
$4,965,136
Total exposure
2
Grants
2
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.6M · FY2021–25$2M$1.5M$1M$500K$0
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$4,965,136 · 2
By mechanism
U01$4,185,542 · 1
U34$779,594 · 1
Top collaborators
- Randi L. Wolf6 shared
Most similar at Columbia University Health Sciences
Same institution · by research overlap
- Randi L. Wolf$2,482,568
- Xiao-Fei Kong$1,076,280
- Thomas D'aunno$1,221,490
- Yian Gu$8,623,940
- Milan N Stojanovic$13,069,170
Others in their field
Other Emerging Leaders on “Cost Effectiveness”
- Valerie Koch · University Corporation For Atmospheric Res$243,972,016
- Yunda Huang · Fred Hutchinson Cancer Center$52,003,716
- John Damon Chodera · Sloan-Kettering Inst Can Research$36,078,498
- Karen Martier · Westat, Inc.$35,207,008
- Gary Fanger · Rise Therapeutics, Llc$21,006,928
- Chani Eduard · Precision Bioservices, Inc.$19,909,203
Research focus
Cost EffectivenessCovid-19 PandemicAcceptability And FeasibilityCostAdoptionCountryAdultAdherenceAutoantibodiesAffectAnemiaBehavioralAntibodiesCeliac DiseaseChemistryClinical DevelopmentClinical ManagementAnxietyClinical TrialsCommunicationAwarenessComplementConsumptionDetection
Grant awards (6)
Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease: The GLUTECH Trial$1,400,000
U01 · FY2025 · DK · contact PI
Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease: The GLUTECH Trial$163,367
U01 · FY2025 · DK · contact PI
Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease: The GLUTECH Trial$1,333,964
U01 · FY2024 · DK · contact PI
Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease: The GLUTECH Trial$1,288,211
U01 · FY2023 · DK · contact PI
Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease$358,413
U34 · FY2022 · DK · contact PI
Evaluation of Novel Technologies to Improve Clinical Management of Celiac Disease$421,181
U34 · FY2021 · DK · contact PI